163 related articles for article (PubMed ID: 8303299)
1. Mapping the lectin-like activity of tumor necrosis factor.
Lucas R; Magez S; De Leys R; Fransen L; Scheerlinck JP; Rampelberg M; Sablon E; De Baetselier P
Science; 1994 Feb; 263(5148):814-7. PubMed ID: 8303299
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor and lymphotoxin. Qualitative and quantitative differences in the mediation of early and late cellular response.
Chaturvedi MM; LaPushin R; Aggarwal BB
J Biol Chem; 1994 May; 269(20):14575-83. PubMed ID: 8182064
[TBL] [Abstract][Full Text] [Related]
3. A computational study of the oligosaccharide binding sites in the lectin-like domain of Tumor Necrosis Factor and the TNF-derived TIP peptide.
Dulebo A; Ettrich R; Lucas R; Kaftan D
Curr Pharm Des; 2012; 18(27):4236-43. PubMed ID: 22697478
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi is lysed by coelomic cytolytic factor-1, an invertebrate analogue of tumor necrosis factor, and induces phenoloxidase activity in the coelomic fluid of Eisenia foetida foetida.
Olivares Fontt E; Beschin A; Van Dijck E; Vercruysse V; Bilej M; Lucas R; De Baetselier P; Vray B
Dev Comp Immunol; 2002 Jan; 26(1):27-34. PubMed ID: 11687260
[TBL] [Abstract][Full Text] [Related]
5. A lymphotoxin-beta-specific receptor.
Crowe PD; VanArsdale TL; Walter BN; Ware CF; Hession C; Ehrenfels B; Browning JL; Din WS; Goodwin RG; Smith CA
Science; 1994 Apr; 264(5159):707-10. PubMed ID: 8171323
[TBL] [Abstract][Full Text] [Related]
6. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.
Kohno T; Brewer MT; Baker SL; Schwartz PE; King MW; Hale KK; Squires CH; Thompson RC; Vannice JL
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8331-5. PubMed ID: 2172983
[TBL] [Abstract][Full Text] [Related]
7. Identification, affinity characterisation and biological interactions of lectin-like peptide-carbohydrate complexes derived from human TNF-alpha using high-resolution mass spectrometry.
Marquardt A; Bernevic B; Przybylski M
J Pept Sci; 2007 Dec; 13(12):803-10. PubMed ID: 17918767
[TBL] [Abstract][Full Text] [Related]
8. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J
Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
10. Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions.
Schuchmann M; Hess S; Bufler P; Brakebusch C; Wallach D; Porter A; Riethmüller G; Engelmann H
Eur J Immunol; 1995 Aug; 25(8):2183-9. PubMed ID: 7664782
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant P60 and P80 receptors.
Higuchi M; Aggarwal BB
Biochem Biophys Res Commun; 1992 Jan; 182(2):638-43. PubMed ID: 1310388
[TBL] [Abstract][Full Text] [Related]
12. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
Browning J; Ribolini A
J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
[TBL] [Abstract][Full Text] [Related]
13. Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
Marshall WL; Brinkman BM; Ambrose CM; Pesavento PA; Uglialoro AM; Teng E; Finberg RW; Browning JL; Goldfeld AE
J Immunol; 1999 May; 162(10):6016-23. PubMed ID: 10229841
[TBL] [Abstract][Full Text] [Related]
14. A 20 amino acid synthetic peptide of a region from the 55 kDa human TNF receptor inhibits cytolytic and binding activities of recombinant human tumour necrosis factor in vitro.
Hwang CD; Gatanaga M; Innins EK; Yamamoto RS; Granger GA; Gatanaga T
Proc Biol Sci; 1991 Aug; 245(1313):115-9. PubMed ID: 1682934
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor.
Pennica D; Lam VT; Weber RF; Kohr WJ; Basa LJ; Spellman MW; Ashkenazi A; Shire SJ; Goeddel DV
Biochemistry; 1993 Mar; 32(12):3131-8. PubMed ID: 8384489
[TBL] [Abstract][Full Text] [Related]
16. Correlation between carbohydrate-binding specificity and amino acid sequence of carbohydrate-binding regions of Cytisus-type anti-H(O) lectins.
Konami Y; Yamamoto K; Osawa T; Irimura T
FEBS Lett; 1992 Jun; 304(2-3):129-35. PubMed ID: 1618311
[TBL] [Abstract][Full Text] [Related]
17. Dichotomal role of TNF in experimental pulmonary edema reabsorption.
Braun C; Hamacher J; Morel DR; Wendel A; Lucas R
J Immunol; 2005 Sep; 175(5):3402-8. PubMed ID: 16116234
[TBL] [Abstract][Full Text] [Related]
18. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
[TBL] [Abstract][Full Text] [Related]
19. An invertebrate TNF functional analogue activates macrophages via lectin-saccharide interaction with ion channels.
Bilej M; Josková R; Van den Bergh R; Procházková P; Silerová M; Ameloot P; De Baetselier P; Beschin A
Int Immunol; 2006 Dec; 18(12):1663-70. PubMed ID: 17035350
[TBL] [Abstract][Full Text] [Related]
20. Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice.
Qin Z; van Tits LJ; Buurman WA; Blankenstein T
Blood; 1995 May; 85(10):2779-85. PubMed ID: 7742538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
